切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2023, Vol. 12 ›› Issue (02) : 76 -80. doi: 10.3877/cma.j.issn.2095-3259.2023.02.003

专家论坛

妊娠期易栓症的自身抗体检测
杨泽俊, 赵茵()   
  1. 华中科技大学同济医学院附属协和医院妇产科,武汉 430030
    华中科技大学同济医学院附属协和医院妇产科,武汉 430030;华中科技大学深圳研究院,深圳 518000
  • 收稿日期:2022-10-08 出版日期:2023-05-18
  • 通信作者: 赵茵
  • 基金资助:
    国家自然科学基金(82171678); 深圳市自然科学基金(JCY20200109140614667)

Detection of autoantibodies in thrombophilia of pregnancy

Zejun Yang, Yin Zhao()   

  • Received:2022-10-08 Published:2023-05-18
  • Corresponding author: Yin Zhao
引用本文:

杨泽俊, 赵茵. 妊娠期易栓症的自身抗体检测[J]. 中华产科急救电子杂志, 2023, 12(02): 76-80.

Zejun Yang, Yin Zhao. Detection of autoantibodies in thrombophilia of pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 76-80.

妊娠期孕妇血液呈高凝状态,在遗传性因素或获得性因素的影响下,孕妇血液的高凝状态更严重。妊娠期易栓症不仅增加静脉血栓栓塞的风险,还可导致不良围产结局,严重危害母婴健康。获得性易栓症的诊断主要依赖临床症状和实验室检查,其中自身抗体是主要的实验室指标。本文主要对妊娠期易栓症自身抗体的种类、在发病机制中的作用、实验室检测方法和诊断价值的研究进展进行论述。

The blood of pregnant women during pregnancy is hypercoagulable. Under the influence of hereditary or acquired factors, the hypercoagulable state of pregnant women′s blood is more serious. Thrombophilia during pregnancy not only increases the risk of venous thromboembolism but also leads to adverse perinatal outcomes, which seriously endangers the health of mothers and infants. The diagnosis of acquired thrombophilia mainly depends on clinical symptoms and laboratory tests, in which autoantibodies are the main laboratory indicators. This review focuses on the research progress of the types of autoantibodies, their role in pathogenesis, laboratory testing methods and diagnostic value in thrombophilia in pregnancy.

[1]
中华医学会血液学分会血栓与止血学组. 易栓症诊断与防治中国指南(2021年版)[J]. 中华血液学杂志202142(11):881-888.
[2]
国家妇幼健康研究会生殖免疫学专业委员会专家共识编写组. 复发性流产合并血栓前状态诊治中国专家共识[J]. 中华生殖与避孕杂志202141(10):861-875.
[3]
Devis P, Knuttinen MG. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management [J]. Cardiovasc Diagn Ther, 2017, 7(Suppl 3):S309-S319.
[4]
Schreiber K, Sciascia S, de Groot PG, et al. Antiphospholipid syndrome [J]. Nat Rev Dis Primers20184:17103.
[5]
Gary T, Belaj K, Bruckenberger R, et al. Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism[J]. Obesity201321(9):E463-E466.
[6]
Houghton DE, Moll S. Antiphospholipid antibodies [J]. Vasc Med, 2017, 22(6):545-550.
[7]
中华医学会围产医学分会. 产科抗磷脂综合征诊断与处理专家共识 [J]. 中华围产医学杂志202023(8):517-522.
[8]
Urbanus RT, de Groot PG. Antiphospholipid antibodies--we are not quite there yet [J]. Blood Rev, 2011, 25(2):97-106.
[9]
Liu TGu JWan L,et al. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort [J]. Arthritis Res Ther, 2020, 22(1):33.
[10]
Linnemann B, Hart C. Laboratory diagnostics in thrombophilia [J]. Hamostaseologie, 2019, 39(1):49-61.
[11]
Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis [J]. J Thromb Haemost, 2009, 7(10):1737-1740.
[12]
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J]. J Thromb Haemost20064(2):295-306.
[13]
Moore GW. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants [J]. Semin Thromb Hemost201440(2):163-171.
[14]
Devreese KMJ. Testing for antiphospholipid antibodies: advances and best practices[J]. Int J Lab Hematol202042 Suppl 1:49-58.
[15]
Wang D, Lv W, Zhang S, et al. Advances in the research on anticardiolipin antibody [J]. J Immunol Res20192019:8380214.
[16]
Meroni PL, Borghi MO. Antiphospholipid antibody assays in 2021: looking for a predictive value in addition to a diagnostic one [J]. Front Immunol, 202112:726820.
[17]
Hu C, Li X, Zhao J, et al. Immunoglobulin a isotype of antiphospholipid antibodies does not provide added value for the diagnosis of antiphospholipid syndrome in a Chinese population [J]. Front Immunol202011:568503.
[18]
Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA [J]. Nat Protoc20083(5):840-848.
[19]
de Groot PG, Meijers JC. β(2) -Glycoprotein Ⅰ:evolution, structure and function[J]. J Thromb Haemost20119(7):1275-1284.
[20]
Giannakopoulos B, Passam F, Rahgozar S, et al. Current concepts on the pathogenesis of the antiphospholipid syndrome[J]. Blood, 2007109(2): 422-430.
[21]
Bettacchioli E, Nafai S, Renaudineau Y. News and meta-analysis regarding anti-beta 2 glycoprotein Ⅰ antibodies and their determination [J]. Clin Immunol, 2019205:106-115.
[22]
Bertolaccini ML, Sanna G. The clinical relevance of noncriteria antiphospholipid antibodies [J]. Semin Thromb Hemost, 2018, 44(5): 453-457.
[23]
Pignatelli P, Ettorre E, Menichelli D, et al. Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management[J]. Haematologica2020105(3):562-572.
[24]
中华医学会风湿病学分会,国家皮肤与免疫疾病临床医学研究中心,中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志202059(3):172-185.
[25]
李嘉欣,张卓莉. 系统性红斑狼疮合并血栓性微血管病的诊治及预后[J]. 中华风湿病学杂志201822(9):642-645.
[26]
尤含笑,赵久良,孙伊多,等. 系统性红斑狼疮患者发生静脉血栓栓塞事件的风险[J]. 中华临床免疫和变态反应杂志201913(3):226-231.
[27]
中国免疫学会临床免疫分会. 自身抗体检测在自身免疫病中的临床应用专家建议[J]. 中华风湿病学杂志201418(7):437-443.
[28]
Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis201978(6):736-745.
[29]
高雅静,庞春艳,王永福. 干燥综合征相关自身抗体检测的研究进展 [J]. 东南大学学报(医学版)202140(5):704-707.
[30]
Gupta S, Gupta N. Sjögren syndrome and pregnancy: a literature review[J]. Perm J201721:16-47.
[31]
吕良敬,倪若柠. 重视复发性流产患者中未分化结缔组织病的诊断[J].诊断学理论与实践201817(3):235-237.
[32]
Spinillo A, Beneventi F, Epis OM, et al. The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome[J]. Am J Obstet Gynecol2008199(6):632.e1-e6.
[1] 肖志满, 龚煜, 谢景凌, 刘斌伟. 上下肢关节镜手术后患者下肢深静脉血栓发生的对比研究[J]. 中华关节外科杂志(电子版), 2023, 17(05): 601-606.
[2] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[3] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[4] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[5] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[6] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[7] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[8] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[9] 黄应雄, 叶子, 蒋鹏, 詹红, 姚陈, 崔冀. 急性肠系膜静脉血栓形成致透壁性肠坏死的临床危险因素分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 413-421.
[10] 王跃, 唐敏, 李鹏超, 吕强. 妊娠期膀胱副神经节瘤伴严重出血一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 410-411.
[11] 杨聚荣. 透析患者妊娠的管理[J]. 中华肾病研究电子杂志, 2023, 12(05): 300-300.
[12] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[13] 王欣, 刘琳, 闻哲嘉, 刘春玲, 张弘, 吕芳. 妊娠前应激暴露对小鼠后续妊娠的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 431-437.
[14] 邹艳丽, 栾文杰, 王淑娟, 刘亚琴, 初桂芝, 李松洋, 王好玲, 张锦婷, 姜鑫, 栾泽东. 早孕期胎儿右位主动脉弓的产前超声诊断学特征[J]. 中华诊断学电子杂志, 2023, 11(04): 227-232.
[15] 尹琛俊, 张喆, 李晓明. 卵圆孔未闭相关血栓形成机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 307-311.
阅读次数
全文


摘要